Industry News (Joint Venture)

Research Agreement Entered To Discover Antifungal Drugs

Published in Blood Weekly, March 3rd, 1997

Alpha-Beta Technology, Inc., Worcester, Massachusetts, announced that it has entered into a research agreement with MycoTox, Inc., Denver, Colorado, for the discovery of anti-fungal drugs.

Under the agreement, MycoTox screens small-molecule carbohydrate compounds generated by Alpha-Beta against its proprietary library of antifungal targets.

"Our drug discovery strategy capitalizes on Alpha-Beta's core carbohydrate technology and on our expertise in infectious disease," said Spiros Jamas, Sc.D., Alpha-Beta. "MycoTox possesses innovative technology that will enable us to accelerate the discovery of new antifungal drugs."

"There...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1997-03-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry